Drug Profile
PDB 093
Alternative Names: WAY PDB 093Latest Information Update: 23 Jan 2001
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antiasthmatics; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 23 Jan 2001 Discontinued-Preclinical for Asthma in USA (Unknown route)
- 23 Jul 1998 No-Development-Reported for Asthma in USA (Unknown route)
- 09 May 1995 New profile